Mo Jain

Mo Jain, MD PhD, is the Founder and CEO of Sapient, a company established in May 2021 that focuses on accelerating human discovery and drug development through advanced analytical mass spectrometry, computational biology, and large-scale clinical studies. In addition, Mo Jain serves as the Director of the Jain Laboratory at the University of California, San Diego, since June 2013, leading a diverse research team in developing next-generation mass spectrometry systems. Mo Jain holds the position of Professor of Medicine & Pharmacology at the University of California, San Diego School of Medicine and has previously held various roles, including Associate Physician and Fellow in Cardiovascular Medicine at Brigham and Women's Hospital. Educational credentials include a Doctor of Medicine and a Doctor of Philosophy in Molecular Physiology from Boston University School of Medicine, along with a Bachelor of Arts from Boston University’s Accelerated Seven-Year Liberal Arts/Medical Education Program.